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Case report

A rare non-oncological pancreatic mass: eosinophilic pancreatitis
diagnosis through EUS-FNA
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(EP) is a rare etiology of chronic pancreatitis, and few cases
have been reported. It is characterized by eosinophilic infiltration of the pancreas and elevated IgE levels. EP is difficult
to distinguish from pancreatic cancer based on clinical
symptoms and auxiliary exams. We present a case of EP
and debate the routine performance of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for resectable pancreatic mass.

Introduction

Case report

Eosinophilic pancreatitis (EP) is an extremely rare etiology of
chronic pancreatitis, and only a few cases have been reported
[1, 2]. It is characterized by diffuse or localized eosinophilic infiltration of the pancreas and elevated IgE levels. Differential diagnosis between EP and pancreatic cancer (PC) is challenging
because clinical symptoms and auxiliary exams (laboratory
tests and radiological evaluation) may be rather similar [3].
Routine endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for resectable pancreatic lesions is controversial
[4]. Some experts advocate that routine FNA may detect a nonsurgical condition and therefore avoid an unnecessary operation and related complications. Conversely, EUS-FNA presents
a substantial false-negative rate and may be associated with
some adverse events, which might postpone or impair a curable resection [5, 6]. We report a case that illustrates the aforementioned debate.

A 37-year-old man with a 4-month history of weight loss, obstructive jaundice, pruritus, and nausea and vomiting was admitted with an acute clinical complaint of fever, cough and dyspnea. He reported alcohol abuse for 15 years but denied any
family medical history of PC. Physical examination revealed
normal general appearance (body mass index = 21 kg/m 2) but
jaundice (2 +/4 +). Abdominal examination showed neither abdominal pain nor palpable masses. Laboratory tests were as follows: hemoglobin, 12.1 g/L; leukocyte count, 9.3 × 10 9/L; neutrophils, 5.6 × 109 (56 %); eosinophils: 0.12 × 109 (12 %) (reference range: 0.0 – 0.06 × 10 9); total bilirubin 3.97 mg/dL (direct
bilirubin: 3.52 mg/dL); alkaline phosphatase, 769 U/L; gammaglutamyl transferase, 591 U/L; AST, 76 U/L; ALT, 72 U/L; and
normal CA, 19.9. Hepatitis serology and autoimmune tests
were negative.
Abdominal ultrasound showed biliary dilation but no cause
for obstruction. Magnetic resonance cholangiopancreatography revealead biliary dilation due to an abrupt irregular narrowing in the distal common bile duct (CBD) without evident lesion
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▶ Fig. 1 EUS image showing a hypoechoic pancreatic head mass.

▶ Fig. 3 Cell block, hematoxylin-eosin staining, 400 × Zoom, showing eosinophils in the pancreas.

▶ Fig. 2 a ERCP showing a distal biliary stricture; b Biliary drainage
with 10 Fr × 7 cm plastic stent.

associated with pancreatic body and tail atrophy and a normal
pancreatic duct. Finally, abdominal computed tomography (CT)
showed a 20-mm mass in the head of the pancreas, hypoattenuating, with no vascular invasion ( ▶ Fig. 1).
Endoscopic ultrasound (EUS) followed by endoscopic retrograde cholangiopancreatography (ERCP) to evaluate the mass
and perform biliary drainage was indicated. EUS demonstrated
a hypoechoic pancreatic head mass measuring 20 mm and a
CBD dilatation. EUS-FNA was performed with a 22-gauge needle (Expect Slimline, Boston Scientific, Marlborough, Massachusetts, United States) but cytology was inconclusive.
ERCP demonstrated mild biliary duct dilatation due to a regular distal biliary stricture, suggesting pancreatic extrinsic compression ( ▶ Fig. 2a). Transpapillary forceps biopsy and brush
cytology were negative for malignancy. A 10 Fr × 7-cm plastic
stent placement ensured adequate CBD drainage ( ▶ Fig. 2b).
After the negative sample results, a multidisciplinary group
discussed surgery versus a new attempt at EUS-FNA. An EUSFNA was indicated, and once again, we used a 22-gauge needle
(Expect Slimline, Boston Scientific, Marlborough, Massachusetts, United States). The new cytological evaluation showed
massive pancreatic eosinophilic infiltration without a considerable increase in the presence of IgG4 positive cells, consistent
with eosinophilic pancreatitis (▶ Fig. 3).
After the diagnosis, the patient was also diagnosed with eosinophilic pneumonia and treated with systemic corticosteroids
for 5 weeks.
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▶ Fig. 4 Post-treatment CT study revealing a mass shrinking and
no biliary dilation.

Post-treatment contrast abdominal CT revealed mass shrinking from 20 mm to 12 mm without biliary tract dilation
(▶ Fig. 4). Repeat complete blood count showed no elevation
of serum IgG4 (121 mg/dL), hemoglobin 16.0 g/L, leukocyte
count 8.3 × 10 9/L, neutrophils 4.6 × 10 9 (46 %), eosinophils:
0.02 × 10 9 (2.0 %), total bilirubin 0.37 mg/dL, alkaline phosphatase 63 U/L, and gamma-glutamyl transferase 132 U/L.
At 1-year follow-up, the patient is asymptomatic on a low
dose of systematic corticosteroids even after biliary stent removal.
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Discussion
EP is a rare etiology of chronic pancreatitis characterized by localized or diffuse eosinophilic infiltration of the pancreas and
increased serum IgE [3]. Usually, the patient presents with a
pancreatic mass due to eosinophilic inflammatory infiltration
associated with obstructive jaundice, as in our case [2, 3].
Many etiologies for EP have been suggested and published
case reports include malignancy, parasitic infection, hypersensitivity to medications (e. g., carbamazepine), milk allergy, atopic diseases, newborn infant of a diabetic mother, and as an association with hypereosinophilic syndrome or eosinophilic gastroenteritis [1, 7].
A diagnosis of EP is often made based on hypereosinophilic
syndrome or eosinophilic gastroenteritis criteria in patients
presenting with gastrointestinal symptoms who exhibit eosinophilic infiltration in histological/cytological samples [3, 4, 8].
Diagnostic criteria for hypereosinophilic syndrome are as
follows: peripheral eosinophil count higher than 1.5 × 10 9 for 6
months; past medical history of rhinitis, asthma or other allergic diseases; eosinophilic infiltration of other organs (digestive
system, skin and/or heart); nad exclusion of other causes for
eosinophilia such as parasitic infestations or leukemia [3, 8].
Regarding the eosinophilic gastroenteritis, which our patient had as well, the diagnostic criteria include presence of abdominal pain, vomiting, nausea, diarrhea, loss of appetite or
any other digestive symptom; intestinal sampling showing eosinophilic infiltration and ruling out parasitic infection; and no
involvement of organs outside the gastrointestinal tract [4].
The main differential diagnosis includes autoimmune pancreatitis (AIP) and PC [3].
EP is difficult to distinguish from AIP because they present
with similar clinical symptoms and radiologic results [3, 7].
However, subtle differences may favor one over the other. ▶ Table 1 outlines characteristics that may help differentiate EP
from AIP.
Both EP and AIP are commonly misdiagnosed as PC due to
the similarity of symptoms and imaging findings. It is important
to recognize that some cases of PC are associated with eosinophilia, which can make the diagnosis of either condition difficult [3].
Definitive diagnosis depends on histological/cytological
findings, assessment of serum tumor marker, absence of pancreatic duct dilation, history of hypereosinophilic syndrome or
eosinophilic gastroenteritis, and response to corticosteroid or/
and cromolyn therapy [4, 9].

Nearly 7 % of patients undergoing pancreatoduodenectomy
for suspected malignancy are ultimately diagnosed with benign
disease. Although some preoperative findings such as abdominal pain, absence of jaundice, normal pancreatic duct and absence of a mass or double duct sign on CT might indicate a benign condition, they are not sufficient to warrant use of conservative therapy [9]. EUS-FNA is an essential procedure for a patient with suspected PC who does not fit the typical demographics/preoperative findings.
Most cases of EP are diagnosed postoperatively. To avoid
such unnecessary surgeries, adequate assessment of the patientʼs medical history and EUS-FNA for tissue sample are fundamental [3, 6]. In our case, even after a negative EUS-FNA, we
decided on another FNA because the patient was young and
well-appearing, and had no dilation of the main pancreatic
duct. However, only after the cytological results were we able
to correlate the findings of the patient's clinical history and laboratory tests and diagnosed the hypereosinophilic syndrome.
There are few reports in the literature of cases of eosinophilic pancreatitis diagnosed by EUS-FNA [1, 8, 10]. As in our patient, adequate control of the disease was achieved using prednisolone or cromolyn [3, 10].

Conclusions
In summary, EP is a rare condition that is frequently misdiagnosed with PC. Clinical history, laboratory tests, radiological exams and tissue sampling are necessary for a definite diagnosis.
Correct and precise diagnosis is crucial and may prevent unnecessary surgery and allow for noninvasive treatment. EUS-FNA
is fundamental if the patient does not fit the typical findings
for PC.
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